LQDA Liquidia Corp Total Asset Value of Company

LQDA (Liquidia Technologies) - company brandmark

A stable staff of specialized engineers and scientists supports the growth of Liquidia Corporation (LQDA), as evidenced by the dynamics of total assets. The 389.68 level captures the latest values of this metric. While PRINT technology for deep lung drug delivery creates the foundation for success, prolonged patent disputes pose serious risks to the operations of Liquidia Corporation.

LQDA (Liquidia Corporation) Company Total Assets history from 07/04/2022 to 10/31/2026

Analytical breakdowns and data insights for company Liquidia Technologies (LQDA)

- market value and analyst target forecast:
Stock Price liquidia.com|LQDA - Price Target Chart
- market capitalization data:
Market Valuation Liquidia Inc.|LQDA - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share Liquidia|LQDA - Book Capitalization|Market Capitalization to Book Value Ratio liquidia.com|LQDA - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Liquidia Corporation|LQDA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Liquidia Inc.|LQDA - Company Aggregate Debts|Debts to Book Capitalization Liquidia Inc.|LQDA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Liquidia|Immediate Liquidity liquidia.com
- net income and valuation multiples indicators:
LQDA - Net Income
Fundamental valuation:Liquidia Corporation
Manufactured products of Liquidia Corporation

Fundamental stock selection requires an analysis of resource efficiency, where the total value of assets and liabilities serves as the basis for assessing profitability. This indicator, reverse-calculated via ROA, measures the scale of Liquidia Corporation (LQDA), reflecting the financial potential for developing innovative pulmonary hypertension treatments through the growth dynamics of assets and resources.

Key competitors

haleon.com (HLN) - Company Total Assets|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value GLPG (Galapagos N.V.)|ANI Pharma (ANIP) - Aggregate Company Assets|Cumulative Company Assets Afrezza|AMPH (Amphastar Pharmaceuticals) - Company Total Assets|Company Total Assets pacira.com|Cumulative Company Assets SPRY (ARS Pharmaceuticals, Inc.)|TBPH (Theravance Biopharma Inc) - Aggregate Asset Value|Aggregate Company Assets Aquestive Pharma AQST|scPharmaceuticals, Inc. (SCPH) - Company Assets|TECX: Cumulative Company Assets|tonixpharma.com - Aggregate Business Assets|SXTC: Company Total Assets|Eupraxia Pharmaceuticals Inc. - Aggregate Asset Value|BHST (BioHarvest) - Company Total Assets|Company Assets Invizyne EXOZ|Aggregate Company Assets Oramed Pharmaceuticals (ORMP)|ENTX (enterabio.com) - Aggregate Asset Value|Aggregate Company Assets MindWalk Holdings Inc. HYFT|ABVC BioPharma Inc. - Aggregate Company Assets|Cumberland Pharma - Company Total Assets|Company Total Asset Base Quantum BioPharma Corp QNTM|FibroGen, Inc. (FGEN) - Aggregate Company Assets|Company Balance Sheet Assets telomirpharma.com TELO|Cumulative Company Assets RANI|Company Total Assets Synergy CHC Corporation|Company Total Assets RLYB|Company Total Asset Base lexariabioscience.com|Company Total Assets PULM (Pulmatrix, Inc.)|PTHL: Total Business Assets|Aptorum - Company Total Assets|Company Total Asset Base Lyra Therapeutics Inc. LYRA|IBO: Company Total Assets|TNF Pharmaceuticals, Inc. (TNFA) - Company Total Assets|Cumulative Company Assets YCBD|PRFX: Aggregate Asset Value|Company Total Assets CYTO|Cumulative Company Assets Lipella Pharmaceuticals Inc LIPO|Aggregate Company Assets Optinose OPTN|Pieris Pharma (PIRS) - Company Assets|PROC - Aggregate Company Assets|Aggregate Asset Value PTPI (petrospharma.com)|Qilian International Holding (QLI) - Aggregate Company Assets|Total Asset Value of Company SLRN (Acelyrin Inc.)|Aggregate Company Assets TFF Pharma